Fundraising Fox
Jonathan Mow
Chief Executive Officer at PhaseBio Pharmaceuticals
Find your path to Jonathan
3 people in our graph can introduce you to Jonathan.
Sign up to see every warm intro you have to Jonathan
- Paths you didn't know you had: your email and LinkedIn already hold routes to Jonathan. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Mow joined PhaseBio as Chief Business Officer in 2012 and led the company as CEO from 2015 to 2023, later serving as Chief Executive Officer of VERALOX Therapeutics. His earlier career included VP of Business Development at Amylin Pharmaceuticals, co-founding Corus Pharma, where he was VP of Commercial and Business Development, and roles at PathoGenesis, Bristol Myers Squibb, and Lederle International.
Frequently asked questions
- Who is Jonathan Mow?
- Mow joined PhaseBio as Chief Business Officer in 2012 and led the company as CEO from 2015 to 2023, later serving as Chief Executive Officer of VERALOX Therapeutics. His earlier career included VP of Business Development at Amylin Pharmaceuticals, co-founding Corus Pharma, where he was VP of Commercial and Business Development, and roles at PathoGenesis, Bristol Myers Squibb, and Lederle International.